moderate thrombocytosis and treatment
TV SHOWS
Watch TV Shows
 
 
VIDEO TESTIMONY
Watch Patient Videos
Watch Patient Videos
 
 
 
TESTIMONIALS
 
 
PATIENT REPORTS
View Investigation Report of patients before and after therapy
 
 
 
 
HEALTH PROBLEM
Consult Dr. Rao Online

 
Go

HOME |

FAQ |

CONTACT US | SITEMAP
Home Disease Index Thrombocytosis

 


Overview

Causes
Symptoms
Risk Factor

Consult the Doctor Back to Disease Index

Overview

 


Thrombocytosis is a medical term used to describe a high number of circulating platelets in the blood. Platelets (also called thrombocytes) are small fragments of cells which, following blood vessel injury stick to the damaged vessel wall and to each other forming a major component of the blood clot. The platelet count in the blood is normally maintained between 150 and 400 million per ml of blood volume. Many factors can influence an individual's platelet count including exercise and racial origin. In thrombocytosis the platelet count is elevated above 400 million per ml and rarely can reach 5000 million per ml.




Causes

 

A high platelet count can occur in many different medical situations but the two basic processes involved include either an increased rate of platelet production (by the cells within the bone marrow) or by reduced removal of platelets from the blood - which is one of the functions of the spleen. Most situations that cause thrombocytosis do so by increasing platelet production, whereas reduced platelet removal occurs following surgical removal of the spleen (splenectomy).

The causes of thrombocytosis are summarised in Table 1 and described in more detail below.

Table 1: Causes of thrombocytosis

Secondary or reactive thrombocytosisInfection (acute and chronic)
Inflammatory disorders (eg Kawasaki's disease)
Chronic iron deficiency
Acute or chronic blood loss
Tissue damage from trauma or surgery
Medicines (steroid, vincristine)
Splenectomy and hyposplenism
Malignancy (Hodgkin's disease, solid tumours)
Rebound from chemotherapy
Primary thrombocytosisEssential thrombocytosis (non-familial)
Essential thrombocytosis (familial)
Chronic myeloid leukaemia
Polycythaemia vera
Myelofibrosis
Myelodysplastic syndromes .

 

Causes of reactive (secondary) thrombocytosis

The causes of reactive (secondary) thrombocytosis are described below.

Inflammatory disorders

These conditions may cause thrombocytosis by similar mechanisms to infections. Kawasaki's disease is a rare condition, mainly affecting children, in which there is widespread inflammation of the arteries. It is characteristically associated with a high platelet count that gradually resolves in the recovery phase. In adults either a high or low platelet count may accompany other features of 'autoimmune' diseases such as rheumatoid arthritis.

Acute and chronic blood loss

The response of the bone marrow to blood loss is to produce not only more red blood cells but also more platelets - this occurs in response to cytokines.

Tissue damage from trauma or surgery

The platelet count will also increase when a relatively large amount of body tissue is damaged either intentionally following surgery or with accidental damage. This is part of the natural defence mechanism to ensure adequate clot formation and prevent fatal bleeding.

Medicines

Rarely treatment with some drugs (steroid, vincristine) causes a transient increase in platelet count. These drugs are sometimes used to treat patients with a low platelet count due to idiopathic thrombocytopenic purpura (ITP).

Underactive or absent spleen

The spleen is one of the major sites for destroying platelets and if it is removed the platelet count usually increases. The increase may remain for a long time but usually it settles back into the normal range. In some conditions the spleen is present but either it does not function properly (for example in some patients with Coeliac disease) or it is shrunken (for example in sickle cell disease) and the platelet count is sometimes elevated in these conditions. In this case examination of blood cells under a microscope may reveal characteristic changes suggesting impaired function of the spleen.

Malignancy

Some cancers can cause a high platelet count either by causing damage to tissues, causing blood loss (for example from the bowel) or by erroneously producing a cytokine that stimulates the bone marrow to produce platelets.

Rebound from chemotherapy

Some chemotherapy drugs exert their effects directly on dividing cells in the body - including the bone marrow where platelets are made. When the body is recovering from the effects of such chemotherapy a transient overproduction of some cells can occur.

Causes of thrombocytosis associated with bone marrow disorders

The causes of thrombocytosisassociated with bone marrow disorders are described below.

Essential thrombocytosis, polycythaemia vera and myelofibrosis

These three conditions form a group of diseases known as the myeloproliferative disorders (MPDs). An elevated platelet count can occur in all of them but in each an increase in a particular cell type predominates. These are the platelets in essential thrombocythaemia (ET), red cells in polycythaemia vera (PV) and fibroblasts (cells which manufacture fibrous tissue) in myelofibrosis (MF).

Chronic myeloid leukaemia

Chronic myeloid leukaemia was in the past grouped with the MPDs but is now classified independently as its course is very different, and it has a distinct biology.

Myelodysplastic syndromes

This is a group of conditions in which the bone marrow manufactures blood cells inefficiently. Usually the platelet count is low in myelodysplasia but in certain subtypes of this disease it may be higher. Sometimes it can be difficult to distinguish between this condition and a MPD and sometimes patients are classified as having an overlap syndrome.



Symptoms

 

 

 

Risk Factors

 

The potential complications arising in a reactive thrombocytosis (RT) include excessive clot (or thrombus) formation due to the increased number of active platelets and, much less commonly, bleeding as platelet function may also be defective in RT. However, although both thrombosis and haemorrhage are potential complications their occurrence in RT is very rare indeed. Generally they will only occur in patients with a combination of a platelet count more than 1000 million per ml plus other risk factors such as dehydration. The major complications that usually arise in this situation actually relate to the underlying cause of the RT.

   Click here for Therapy


Consult the Doctor Back to Disease Index

Top